EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Effect of curcuminoids on contrast-induced acute kidney injury after elective coronary angiography or intervention: A pilot randomized, double-blind, placebo-controlled study

Kajohnsak Noppakun, Janjira Jitraknatee, Yuttitham Suteeka, Chidchanok Ruengorn, Surapon Nochaiwong, Siriluck Gunaparn, Arintaya Phrommintikul, Wanwarang Wongcharoen

Cardiorenal Medicine · 2024

DOI: 10.1159/000537710 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cardiorenal Medicine, 2024. Verfasst von Kajohnsak Noppakun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Hauptthemen laut MEDLINE: Acute Kidney Injury, Coronary Angiography, Contrast Media, Percutaneous Coronary Intervention. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The role of curcuminoids, a striking antioxidant, in prevention of contrast-induced acute kidney injury (CI-AKI) remains unknown. We aim to evaluate the efficacy and safety of curcuminoids in preventing CI-AKI in patients undergoing elective coronary angiography (CAG) and/or percutaneous coronary intervention (PCI).

Methods

We randomized 114 patients who were undergoing elective CAG and/or PCI to receive curcuminoids, 4 grams/day (1 day before, and 1 day after the procedure, n=56) or placebo (n=58). Serum creatinine was assessed at baseline, 12, 24 and 48 hours after contrast exposure. The primary endpoint was development of CI-AKI defined as serum creatinine increase ≥0.3 mg/dL within 48 hours after contrast exposure. The secondary endpoint was the occurrence of kidney injury defined by >30% increase in urine neutrophil gelatinase-associated lipocalin (NGAL).

Results

Baseline characteristics were comparable between the two groups. Seven (12.7%) in curcuminoids group and eight (14.0%) in placebo group developed CI-AKI (p=0.84). The incidence of increased urine NGAL was comparable in the placebo and curcuminoids groups (39.6% vs. 50%, respectively; p=0.34). None in both groups had drug-related adverse events.

Conclusion

This is a pilot study to demonstrate the safety and tolerability of curcuminoids in patients undergoing elective CAG and/or PCI. Curcuminoids have no protective effects against kidney injury after elective CAG and/or PCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryCoronary AngiographyContrast MediaPercutaneous Coronary InterventionHumansMaleFemaleDouble-Blind MethodPilot ProjectsAgedMiddle AgedLipocalin-2CreatinineAntioxidantsCurcuminDiarylheptanoids

Stichwörter der Autor:innen

Acute kidney diseaseAcute renal failureContrast-associated nephropathyContrast-induced nephropathyCurcuminoids

Substanzen

Contrast MediaLipocalin-2CreatinineAntioxidantsCurcuminDiarylheptanoids

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Pharmacoepidemiology and Statistics Research Center, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand.
  • Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Zitieren

APA

Noppakun, K., Jitraknatee, J., Suteeka, Y., Ruengorn, C., Nochaiwong, S., Gunaparn, S., Phrommintikul, A., & Wongcharoen, W. (2024). Effect of curcuminoids on contrast-induced acute kidney injury after elective coronary angiography or intervention: A pilot randomized, double-blind, placebo-controlled study. Cardiorenal Medicine. https://doi.org/10.1159/000537710

Vancouver

Noppakun K, Jitraknatee J, Suteeka Y, Ruengorn C, Nochaiwong S, Gunaparn S, et al. Effect of curcuminoids on contrast-induced acute kidney injury after elective coronary angiography or intervention: A pilot randomized, double-blind, placebo-controlled study. Cardiorenal Medicine. 2024. doi:10.1159/000537710

BibTeX
@article{Noppakun2024,
  author = {Noppakun, Kajohnsak and Jitraknatee, Janjira and Suteeka, Yuttitham and Ruengorn, Chidchanok and Nochaiwong, Surapon and Gunaparn, Siriluck and Phrommintikul, Arintaya and Wongcharoen, Wanwarang},
  title = {Effect of curcuminoids on contrast-induced acute kidney injury after elective coronary angiography or intervention: A pilot randomized, double-blind, placebo-controlled study},
  journal = {Cardiorenal Medicine},
  year = {2024},
  doi = {10.1159/000537710}
}
Kostenlos starten →